Table 1.
Group (n)a | PRRSV type | Sample type | No. of positive boars at the indicated day postinfection |
||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
−42 | −21 | −7 | 0 | 4 | 7 | 10 | 14 | 18 | 21 | 25 | 28 | 32 | 35 | 39 | 42 | 46 | 49 | 53 | 56 | 60 | |||
T01 (5) | European | Serum | 0 | 0 | 0 | 0 | 5 | 5 | 5 | 5 | 4 | 3 | 4 | 4 | 2 | 2 | 2 | 2 | 0 | 0 | 0 | 0 | 0 |
European | Semen | 0 | 0 | 0 | 0 | 5 | 5 | 5 | 4 | 3 | 3 | 2 | 3 | 2 | 0 | 3 | 3 | 2 | 0 | 2 | 0 | 0 | |
Vaccine | Serum | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Vaccine | Semen | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
T02 (5) | North American | Serum | 0 | 0 | 0 | 0 | 5 | 5 | 5 | 4 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
North American | Semen | 0 | 0 | 0 | 0 | 5 | 5 | 5 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Vaccine | Serum | 0 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Vaccine | Semen | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
T03 (5) | European | Serum | 0 | 0 | 0 | 0 | 5 | 5 | 5 | 5 | 4 | 4 | 3 | 2 | 3 | 2 | 2 | 2 | 0 | 0 | 0 | 0 | 0 |
European | Semen | 0 | 0 | 0 | 0 | 5 | 5 | 5 | 4 | 3 | 2 | 4 | 0 | 3 | 0 | 2 | 0 | 3 | 0 | 3 | 0 | 0 | |
T04 (5) | North American | Serum | 0 | 0 | 0 | 0 | 5 | 5 | 5 | 5 | 5 | 4 | 3 | 2 | 4 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
North American | Semen | 0 | 0 | 0 | 0 | 5 | 5 | 5 | 3 | 3 | 3 | 3 | 0 | 4 | 2 | 4 | 3 | 0 | 2 | 3 | 0 | 0 | |
T05 (5) | Vaccine | Serum | 0 | 3 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Vaccine | Semen | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
n, number of boars in group.